Distant disease-free survival as a surrogate endpoint for overall survival in randomised trials of neoadjuvant therapy for early breast cancer: a pooled analysis of GBG and AGO-B Study Group trials

作者：Fabio Conforti, Johannes Holtschmidt, Valentina Nekljudova, Isabella Sala, Eleonora Pagan, Christine Solbach, Michael Untch, Carsten Denkert, Vincenzo Bagnardi, Laura Pala, Peter A. Fasching, Andreas Schneeweiß, Hans‐Joachim Lück, Giuseppe Viale, Tommaso De Pas, Marion van Mackelenbergh, Jens Huober, Volkmar Müller, Theresa Link, Thomas Karn, Mattea Reinisch, Frederik Marmé, Vesna Bjelic-Radisic, Christian Schem, Andreas Hartkopf, Elmar Stickeler, Claus Hanusch, Jens‐Uwe Blohmer, Tanja Fehm, Kerstin Rhiem, Richard D. Gelber, S. Loibl · 发表于：The Lancet Oncology · 年份：2025 · DOI：10.1016/s1470-2045(25)00546-7 · 被引用次数：5 · 研究领域：Breast Cancer Treatment Studies、Medical Imaging Techniques and Applications、Global Cancer Incidence and Screening